Prof. ERDİNÇ DURSUN

Publication Network

Articles 35

1. The mRNA Expression Levels of General Transcription Factors Altered in Alzheimer Cases Possibly Due to Amyloid Beta 1-42 Exposure.

İlhan N., Keskin E., Şahin E., Alaylıoğlu M., Samancı B., Çamoğlu T., et al.

Noro psikiyatri arsivi , vol.63, pp.341-349, 2026 (SCI-Expanded, Scopus, TRDizin)

2. Increased plasma soluble TREM2 levels in non-Alzheimer’s dementia

Güven G., Gezegen H., ŞAHİN E., Samancı B., Hanağası H., Gürvit H., et al.

Acta Neurologica Belgica , 2026 (SCI-Expanded, Scopus)

3. The CSF Levels of Mitochondrial Phosphoenolpyruvate Carboxykinase 2 as a Novel Biomarker in Alzheimer’s Disease

İlhan N., Şahin E., Ildız S., Samancı B., Sordu P., Alaylıoğlu M., et al.

Molecular Neurobiology , vol.63, no.1, 2026 (SCI-Expanded, Scopus)

4. Characterization of tRNA-derived fragments in the small neuron-derived extracellular vesicles of Alzheimer's disease patients

Arioz B. I., Binokay L., Tastan B., Genc B., Cotuk A., DURSUN E., et al.

Brain Research , vol.1862, 2025 (SCI-Expanded, Scopus)

5. Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis

Gezegen H., ALAYLIOĞLU M., Şahin E., Swann O., Veleva E., Güven G., et al.

Alzheimer's and Dementia , vol.21, no.7, 2025 (SCI-Expanded, Scopus)

6. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview

Delaby C., Ladang A., Martinez-Yriarte J., Zecca C., Logroscino G., Körtvelyessy P., et al.

Alzheimer's and Dementia , vol.21, no.6, 2025 (SCI-Expanded, Scopus)

7. Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.

Sordu P., Alaylıoğlu M., Samancı B., Bulu E., Güleç Z. E. K., Bilgiç B., et al.

Journal of Alzheimer's disease : JAD , vol.105, pp.481-493, 2025 (SCI-Expanded, Scopus)

8. Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease

Ayaz G., SORDU DELİBALTA P., KÜÇÜKSEZER U. C., HANAĞASI H. A., ALAYLIOĞLU M., GÜRVİT İ. H., et al.

JOURNAL OF ALZHEIMERS DISEASE , vol.105, no.1, pp.172-185, 2025 (SCI-Expanded, Scopus)

9. Serum and Saliva Biomolecules in Periodontitis Patients with and without Alzheimer's Disease

ÖZTÜRK D., MİDİ İ., ALAYLIOĞLU M., Tuncer E., GEZEN AK D., DURSUN E., et al.

Nigerian Journal of Clinical Practice , vol.28, no.3, pp.409-416, 2025 (SCI-Expanded, Scopus)

10. A Novel and Robust Protocol for Differentiation of SH-SY5Y Neuroblastoma Cells into Neuron Like Cells

ALAYLIOĞLU M., Keskin E., Şengül Yediel B., DURSUN E., GEZEN AK D.

Noropsikiyatri Arsivi , vol.61, no.3, pp.255-264, 2024 (SCI-Expanded, Scopus, TRDizin)

11. Links between sleep apnea and cognitive impairment: Hypoxia, cytokines, molecular chaperones and mitochondrial pathways

BENBİR ŞENEL G., Sordu P., Sahin M. T., Altun E. N., GEZEN AK D., DURSUN E., et al.

JOURNAL OF SLEEP RESEARCH , 2024 (SCI-Expanded, Scopus)

12. Fibrillar Alpha-Synuclein Alters the Intracellular Chaperone Levels within Hours of Its Internalization

Çamoğlu T., Yurttaş Z., Kına Ü. Y., Sut P. A., Şahin F., Dursun E., et al.

ACS OMEGA , 2024 (SCI-Expanded, Scopus)

13. Vitamin D and behavioral disorders in older adults: results from the CLIP study

Gilbert L., Bourgeais A., Karras S. N., GEZEN AK D., DURSUN E., Annweiler C.

Journal of Nutrition, Health and Aging , vol.28, no.4, 2024 (SCI-Expanded, Scopus)

14. Efficiency of the Vitamin D Status Diagnosticator amongst Geriatric Patients with COVID-19

Charonnat C., Sanchez-Rodriguez D., Karras S. N., GEZEN AK D., DURSUN E., Annweiler C.

Nutrients , vol.16, no.6, 2024 (SCI-Expanded, Scopus)

15. The relations of circulating agouti-related peptide and leptin with altered sleep architecture in patients with active Cushing's disease: a pilot study

Sulu C., Senel G., Koca O., Alaylioglu M., Demir A. N., Durcan E., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.47, no.1, pp.167-178, 2024 (SCI-Expanded, Scopus) Sustainable Development

16. Amyloid β,α-Synuclein and Amyloid β-α-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells.

Keskin E., Gezen-Ak D., Dursun E.

ACS omega , vol.8, no.48, pp.45519-45534, 2023 (SCI-Expanded, Scopus)

17. Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration

GEZEN AK D., DURSUN E.

Journal of Alzheimer's Disease , vol.95, no.4, pp.1273-1299, 2023 (SCI-Expanded, Scopus)

18. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement.

KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.

Multiple sclerosis and related disorders , vol.78, pp.104940, 2023 (SCI-Expanded, Scopus)

19. Vitamin D receptor regulates transcription of mitochondrial DNA and directly interacts with mitochondrial DNA and TFAM

Gezen-Ak D., Alaylıoğlu M., Yurttaş Z., Çamoğlu T., Şengül B., İşler C., et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY , vol.116, 2023 (SCI-Expanded, Scopus) Sustainable Development

20. Delta Secretase and BDNF Signalling in Alzheimer’s Disease

Unlu B., Ildiz S., GEZEN AK D., DURSUN E.

Experimed , vol.13, no.1, 2023 (Scopus, TRDizin)

21. Could Amyloid-beta 1-42 or alpha-Synuclein Interact Directly with Mitochondrial DNA? A Hypothesis

GEZEN AK D., Yurttas Z., Camoglu T., DURSUN E.

ACS CHEMICAL NEUROSCIENCE , vol.13, no.19, pp.2803-2812, 2022 (SCI-Expanded, Scopus)

22. Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry

Karras S. N., DURSUN E., ALAYLIOĞLU M., GEZEN AK D., Pilz S., Annweiler C., et al.

NUTRIENTS , vol.14, no.18, 2022 (SCI-Expanded, Scopus)

23. mir210 and BCL2 Expressions in Patients with Acute Myeloid Leukemia

Göktan H., Kuru R. D., Yılmaz Ş., Alaylıoğlu M., Dursun E., Ak D., et al.

BEZMIALEM SCIENCE , no.4, pp.453-460, 2022 (ESCI)

24. Classical complement pathway factor alterations in narcolepsy

YÜCEER H., GEZEN AK D., BENBİR ŞENEL G., DURSUN E., Yilmaz V., KARADENİZ D., et al.

ACTA NEUROPSYCHIATRICA , vol.34, no.4, pp.212-219, 2022 (SCI-Expanded, Scopus) Sustainable Development

25. Kv5.1 antibody in epilepsy patients with unknown etiology

Kucukali C. I., Sengul B., GEZEN AK D., DURSUN E., Erdag E., AKPINAR G., et al.

EPILEPSY RESEARCH , vol.182, 2022 (SCI-Expanded, Scopus)

26. **Genetic variants of vitamin D metabolism-related DHCR7/NADSYN1 locus and CYP2R1 gene are associated with clinical features of Parkinson's disease.**

Alaylioglu M., Dursun E., Genc G., Sengul B., BİLGİÇ B., Gunduz A., et al.

The International journal of neuroscience , vol.132, no.5, pp.439-449, 2022 (SCI-Expanded, Scopus)

27. Vitamin D mitigates atherosclerosis risk in TNF-alpha-induced endothelial cells

Onal B., Alaylioglu M., DURSUN E., GEZEN AK D.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , vol.21, no.4, pp.701-706, 2022 (SCI-Expanded, Scopus)

28. A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health

Grant W. B., Al Anouti F., Boucher B. J., DURSUN E., GEZEN AK D., Jude E. B., et al.

NUTRIENTS , vol.14, no.3, 2022 (SCI-Expanded, Scopus) Sustainable Development

29. Pleiotropic effects of pitavastatin: a pilot study using the saphenous vein endothelial cell model of endothelial injury and prevention of atherosclerosis

Onal B., Alaylioglu M., Yenmis G., Dogan A. S., Dursun E., Gezen-Ak D., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.14, pp.5210-5217, 2022 (SCI-Expanded, Scopus) Sustainable Development

30. Upregulation of Irisin and Vitamin D-Binding Protein Concentrations by Increasing Maternal 25-Hydrovitamin D Concentrations in Combination with Specific Genotypes of Vitamin D-Binding Protein Polymorphisms

Karras S. N., DURSUN E., ALAYLIOĞLU M., GEZEN AK D., Al Anouti F., Pilz S., et al.

NUTRIENTS , vol.14, no.1, 2022 (SCI-Expanded, Scopus) Sustainable Development

31. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., Cakar A., Demirci H., ALAYLIOĞLU M., GEZEN AK D., DURSUN E., et al.

ACTA NEUROLOGICA SCANDINAVICA , vol.144, no.6, pp.640-646, 2021 (SCI-Expanded, Scopus)

32. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Gönen M. S., Alaylıoğlu M., Durcan E., Özdemir Y., Şahin S., Konukoğlu D., et al.

NUTRIENTS , no.11, 2021 (SCI-Expanded, Scopus)

33. Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause

Savas M., Tzartos J., KÜÇÜKALİ C. İ., DURSUN E., Karagiorgou K., GEZEN AK D., et al.

ACTA NEUROLOGICA BELGICA , vol.121, no.5, pp.1275-1280, 2021 (SCI-Expanded, Scopus)

34. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.

ATASOY I. L., DURSUN E., GEZEN AK D., METİN D., ÖZTÜRK SEZGİN M., YILMAZER S.

JOURNAL OF CHEMICAL NEUROANATOMY , vol.30, no.80, pp.19-26, 2016 (SCI-Expanded, Scopus)

35. Glia derived neurotrophic factor: Its regulation by vitamin D and possible relation to neurodegeneration

ULUTİN A. N. T., GEZEN AK D., DURSUN E., YıLMAZER S.

BİOCHEMISTRY ANALYTICAL BIOCHEMISTRY , vol.5, no.3, pp.48, 2016 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences 40

1. The Effect of Amyloid Beta 1-42 and 1-40 on the Expression of Mitochondrial DNA-Encoded Genes

BATU OTO B., YURTTAŞ Z., ÇAMOĞLU T., ŞENGÜL YEDİEL B., Ildiz S., Ilhan N., et al.

58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, Italy, 24 - 27 May 2025, vol.33, pp.285, (Summary Text)

2. Clinical and Molecular Landscape of Amyotrophic Lateral Sclerosis Patients with OPTN Variants from Turkey and Possible Therapeutic Response to Inhibation of RIPK1

DURMUŞ TEKÇE H., ERZURUMLUOĞLU GÖKALP E., Gezenak D., Dursun E., Alaylioglu M., ÇAKAR A., et al.

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

3. Reduced cerebrospinal fluid levels of the PCK2 protein in patients with Alzheimer's disease

Ilhan N., Ildiz S., Sahin E., SORDU DELİBALTA P., SAMANCI B., ALAYLIOĞLU M., et al.

57th Conference of the European-Society-of-Human-Genetics (ESHG), Berlin, Germany, 1 - 04 June 2024, vol.32, pp.1502-1503, (Summary Text)

4. possible diagnostic biomarkers in the differential diagnosis of autoimmune demyelinating central nervous system diseases: sorcin and clic1

KARAASLAN Z., Yediel B. S., ŞANLI E., YÜCEER KORKMAZ H., DURSUN E., GEZEN AK D., et al.

9th Joint ECTRIMS-ACTRIMS meeting, Milan, Italy, 11 - 13 October 2023, pp.574-575, (Summary Text)

5. Cognitive involvement in ATTR amyloidosis (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., Alaylioglu M., GEZEN AK D., DURSUN E., et al.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 January 2020, vol.25, pp.527, (Summary Text)

6. MATERNAL FOKL VDR POLYMORPHISM IS A DETERMINANT OF BOTH MATERNAL AND NEONATAL 25(OH)D STATUS AT BIRTH: A VALIDATION COHORT FROM NORTHERN GREECE

Karras S., Koufakis T., Goulis D., Annweiler C., Dursun E., Gezen-Ak D., et al.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), Paris, France, 4 - 07 April 2019, vol.30, (Summary Text)

7. DETERMINANTS OF NEONATAL 25(OH)D STATUS IN A GREEK POPULATION COHORT

Karras S., Koufakis T., Goulis D., Annweiler C., Dursun E., Gezen-Ak D., et al.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), Paris, France, 4 - 07 April 2019, vol.30, (Summary Text)

8. Novel anti-neuronal antibodies in idiopathic intracranial hypertension patients

Tuzun E., Altiokka-Uzun G., Erdag E., Gezen-Ak D., Dursun E., Kucukali C. I., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

9. The effect of tau hyperphosphorylation on Pin1 expression in primary cortical neurons.

Metin D., GEZEN AK D., DURSUN E., Atasoy İ., YILMAZER S., Karabay Korknmaz A., et al.

EMC2016 (European Microscopy Congress 2016), Lyon, France, 28 August - 02 September 2016, (Full Text)

10. OKA induced tau hyperphosphorylation decrease BDNF protein levels in primary cortical neuron cultures

Atasoy İ., YILMAZER S., DURSUN E., METİN D., ÖZTÜRK SEZGİN M., GEZEN AK D.

EMC2016 (European Microscopy Congress 2016), Lyon, France, 28 August - 02 September 2016, pp.0-53, (Full Text)

11. Kültürdeki nöronlarda OKA ile indüklenen Tau hiperfosforilasyonunun BDNF proteini üzerindeki etkilerinin immünfloresan ve ELISA yöntemleriyle incelenmesi.

ATASOY I. L., DURSUN E., GEZEN AK D., Metin D., ÖZTÜRK SEZGİN M., YILMAZER S.

14.Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, vol.1, no.1, pp.1, (Summary Text)

12. Clusterin polimorfizmleri ile geç başlangıçlı Alzheimer hastalığı arasındaki ilişki.

Alaylıoğlu M., GEZEN AK D., BİLGİÇ B., Eker E., DURSUN E., Gürvit H., et al.

14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, vol.1, no.1, pp.1, (Summary Text)

13. Association Between Clusterin Polymorphisms and Alzheimer’s Disease.

Alaylıoğlu M., GEZEN AK D., DURSUN E., HANAĞASI H. A., BİLGİÇ B., GÜRVİT İ. H., et al.

Alzheimer’s Association International Conference (AAIC 2015), 17-23 July, 2015 Washington, USA, Washington, United States Of America, 17 - 23 July 2015, pp.1, (Full Text)

14. Vitamin D Dependent Regulation of Gamma Secretase Complex.

DURSUN E., ATASOY I. L., Alaylıoğlu M., YILMAZER S., GEZEN AK D.

Alzheimer’s Association International Conference (AAIC 2015), 17-23 July, 2015 Washington, USA, Washington, United States Of America, 17 - 23 July 2015, pp.1-2, (Full Text)

15. Compromised Regulation of Serum Cytokine Levels and BDNF Due to Low Levels of Vitamin D in Patients with Early or Late Onset Alzheimer’s Disease or Parkinson’s Disease.

GEZEN AK D., BİLGİÇ B., HANAĞASI H. A., ERTAN F. S., LOHMANN E., ATASOY I. L., et al.

Alzheimer’s Association International Conference (AAIC 2015), 17-23 July, 2015 Washington, USA, Washington, United States Of America, 17 - 23 July 2015, pp.1-2, (Summary Text)

16. The effect of vitamin D treatment on GLIA derived neurotrophic factor in cortical neurons

Yilmazer S., Ulutin T., Dursun E., Gezen-Ak D.

16th Annual Conference of the International-Society-for-Bipolar-Disorders, Seoul, South Korea, 18 - 21 March 2014, vol.16, pp.87-88, (Summary Text)

17. Polymorphisms in Her2/Neu and MMP1 genes and associations with breast cancer risk

Öztürk M., Kaya-Dagistanli F., Dursun E., Gezen-Ak D., Cagatay P., Ilvan S., et al.

38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey And Alderney, 6 - 11 July 2013, vol.280, pp.74, (Summary Text) Sustainable Development

18. Serum complement factor H levels in late onset Alzheimer's disease

Yilmazer S., Gezen-Ak D., Dursun E., Hanagasi H., Bilgic B., Lohman E., et al.

38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey And Alderney, 6 - 11 July 2013, vol.280, pp.430, (Summary Text)